|

Lumateperone 42 mg Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 4: 2

Top Sponsors

  • Massachusetts General Hospital1
  • Jason Careri1

Indications

  • Bipolar Depression Depressed Phase1
  • Social Anxiety Disorder (SAD)1
  • Obesity & Overweight1
  • Depression1
  • Anxiety1

Boston, Massachusetts1 trial

The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression

Massachusetts General Hospital

Phase 4

New York, New York1 trial

Caplyta Versus Placebo for Adults With Social Anxiety Disorder

IMA Clinical Research

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.